Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bupivacaine+epinephrine 0.25%/1:200000 sterile wrapped injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine+adrenaline 0.5%/1:200000 sterile wrapped injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate+epinephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine hydrochloride+adrenaline 0.5%/50micrograms/10mL(1:200000) injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bupivacaine hydrochloride 2.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine hydrochloride+epinephrine 0.75%/1:200000 injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prilocaine hydrochloride 4%/epinephrine 200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine hydrochloride + epinephrine 5mg/5mcg injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine hydrochloride + epinephrine 7.5mg/0.005mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine hydrochloride 2.5mg/epinephrine bitartrate 5mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline measurement, standing |
Component |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Epinephrine measurement, supine |
Component |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Epinephrine measurement |
Component |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Urine adrenaline measurement |
Component |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Serum adrenaline measurement |
Component |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Adrenaline/creatinine ratio measurement |
Component |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
24 hour urine adrenaline output measurement |
Component |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Plasma adrenaline measurement |
Component |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
24 hour urine free epinephrine output measurement |
Component |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Urine free adrenaline measurement |
Component |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Articaine hydrochloride+epinephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lidocaine hydrochloride 10%/epinephrine 0.1% topical iontophoretic patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline- and chlorphenamine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Racepinephrine |
Is a |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
épinéphrine 1:1 000, 500 microgrammes/0,5 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
épinéphrine 1:10 000, 100 microgrammes/1 mL, seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional adrenalin poisoning |
Causative agent (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction to adrenaline, epinephrine |
Causative agent (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline- and mepivacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction caused by epinephrine (disorder) |
Causative agent (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing epinephrine and guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing epinephrine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing epinephrine and etidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Injection of epinephrine (procedure) |
Direct substance |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing epinephrine in oropharyngeal dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing epinephrine in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing epinephrine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Injection of epinephrine into lesion of duodenum for hemostasis |
Direct substance |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Accidental poisoning by adrenalin |
Causative agent (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline challenge tests |
Component |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Epinephrine + prilocaine hydrochloride 5mcg/40mg injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Articaine hydrochloride 40mg/mL + epinephrine 1:200000 injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline- and lidocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing epinephrine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Epinephrine bitartrate |
Is modification of (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline hydrochloride |
Is modification of (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Racepinephrine |
Is modification of (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline acetate |
Is modification of (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline- and zinc sulfate-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lidocaine hydrochloride+epinephrine 4% conventional release nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing epinephrine in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline 10 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline 10 mg/mL eye drops |
Has precise active ingredient |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
Has precise active ingredient |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
Has basis of strength substance (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/5 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/5 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/10 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/10 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely epinephrine 300 microgram/0.3 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine 300 microgram/0.3 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing epinephrine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline- and guanethidine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline- and zinc-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bupivacaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only chlorphenamine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only cocaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Adrenaline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only epinephrine and etidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline and guanethidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline and mepivacaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline and pilocarpine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Adrenaline and zinc only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline- and zinc sulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline and fluorouracil only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Adrenaline and guanethidine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline and lidocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline and zinc sulfate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only epinephrine and zinc sulfate in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only epinephrine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only epinephrine in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline 5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline 5 mg/mL eye solution |
Has precise active ingredient |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 5 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |